Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Inotek Pharmaceuticals Corp (ITEK)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Sio Capital

Michael Castor

726,900 $1,454 0.81%
2. 237,135 $474 0.4%
3.
Kingdon Capital

Mark Kingdon

9,700,000 $5,723 0.31%
4.
DAFNA Capital ManagementBOND

Nathan Fischel

600,000 $372 0.31%
5.
OrbiMed AdvisorsBOND

Samuel Isaly

7,000,000 $4,433 0.05%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaning Holdings Date Form 4
$1.75 60,000 Officer, Director 62,765 2017-01-06 Filing
$9.03 10,000 Director 10,000 2016-05-13 Filing
$6.00 212,375 Large Shareholder 1,292,584 2015-02-23 Filing
$6.00 603,832 Large Shareholder, Director 2,277,139 2015-02-23 Filing
$6.00 603,832 Large Shareholder 2,277,139 2015-02-23 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 2,627,790 $5,256 7.38%
2. 477,763 $956 1.25%
3. 10,200,000 $6,557 1.23%
4. 852,022 $1,704 0.43%
5. 2,000,000 $1,190 0.28%
News See All